Genomic Imprinting in Turner Syndrome: Effects on Response to Growth Hormone and on Risk of Sensorineural Hearing Loss

Context: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,Xmaternal and 45,Xpaternal individuals. Objective and Design: We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-s...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 91; no. 8; pp. 3002 - 3010
Main Authors Hamelin, Catherine E., Anglin, Greg, Quigley, Charmian A., Deal, Cheri L.
Format Journal Article
LanguageEnglish
Published Bethesda, MD Oxford University Press 01.08.2006
Copyright by The Endocrine Society
Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Context: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,Xmaternal and 45,Xpaternal individuals. Objective and Design: We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height. Methods and Results: Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an Xmaternal, whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact Xpaternal. No significant differences were noted between Xmaternal and Xpaternal subjects for parents’ heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with Xmaternal, baseline height sd score correlated with midparental height (all: r = 0.511, P < 0.001; Xmaternal: r = 0.535, P = 0.001) and with mother’s height (all: r = 0.510, P < 0.001; Xmaternal: r = 0.574, P < 0.001) but only weakly with father’s height (all: r = 0.334, P = 0.015; Xmaternal: r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with Xmaternal had a greater mean height gain than those with Xpaternal (sd score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04–0.82, P = 0.030, and for 45,X was +0.64 and 0.06–1.21, P = 0.031); X-linked imprinting explained 36–53% of the GH response. After pure tone audiometry testing, Xmaternal subjects were also less likely (P = 0.040) to have sensorineural hearing loss than Xpaternal subjects. Conclusion: This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.
AbstractList Context: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,Xmaternal and 45,Xpaternal individuals. Objective and Design: We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height. Methods and Results: Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an Xmaternal, whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact Xpaternal. No significant differences were noted between Xmaternal and Xpaternal subjects for parents’ heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with Xmaternal, baseline height sd score correlated with midparental height (all: r = 0.511, P < 0.001; Xmaternal: r = 0.535, P = 0.001) and with mother’s height (all: r = 0.510, P < 0.001; Xmaternal: r = 0.574, P < 0.001) but only weakly with father’s height (all: r = 0.334, P = 0.015; Xmaternal: r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with Xmaternal had a greater mean height gain than those with Xpaternal (sd score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04–0.82, P = 0.030, and for 45,X was +0.64 and 0.06–1.21, P = 0.031); X-linked imprinting explained 36–53% of the GH response. After pure tone audiometry testing, Xmaternal subjects were also less likely (P = 0.040) to have sensorineural hearing loss than Xpaternal subjects. Conclusion: This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.
Context: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,Xmaternal and 45,Xpaternal individuals. Objective and Design: We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height. Methods and Results: Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an Xmaternal, whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact Xpaternal. No significant differences were noted between Xmaternal and Xpaternal subjects for parents’ heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with Xmaternal, baseline height sd score correlated with midparental height (all: r = 0.511, P < 0.001; Xmaternal: r = 0.535, P = 0.001) and with mother’s height (all: r = 0.510, P < 0.001; Xmaternal: r = 0.574, P < 0.001) but only weakly with father’s height (all: r = 0.334, P = 0.015; Xmaternal: r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with Xmaternal had a greater mean height gain than those with Xpaternal (sd score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04–0.82, P = 0.030, and for 45,X was +0.64 and 0.06–1.21, P = 0.031); X-linked imprinting explained 36–53% of the GH response. After pure tone audiometry testing, Xmaternal subjects were also less likely (P = 0.040) to have sensorineural hearing loss than Xpaternal subjects. Conclusion: This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.
Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X(maternal) and 45,X(paternal) individuals. We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height. Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an X(maternal), whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact X(paternal). No significant differences were noted between X(maternal) and X(paternal) subjects for parents' heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with X(maternal), baseline height sd score correlated with midparental height (all: r = 0.511, P < 0.001; X(maternal): r = 0.535, P = 0.001) and with mother's height (all: r = 0.510, P < 0.001; X(maternal): r = 0.574, P < 0.001) but only weakly with father's height (all: r = 0.334, P = 0.015; X(maternal): r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with X(maternal) had a greater mean height gain than those with X(paternal) (sd score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04-0.82, P = 0.030, and for 45,X was +0.64 and 0.06-1.21, P = 0.031); X-linked imprinting explained 36-53% of the GH response. After pure tone audiometry testing, X(maternal) subjects were also less likely (P = 0.040) to have sensorineural hearing loss than X(paternal) subjects. This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.
Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X(maternal) and 45,X(paternal) individuals.CONTEXTEvidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X(maternal) and 45,X(paternal) individuals.We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height.OBJECTIVE AND DESIGNWe evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height.Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an X(maternal), whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact X(paternal). No significant differences were noted between X(maternal) and X(paternal) subjects for parents' heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with X(maternal), baseline height sd score correlated with midparental height (all: r = 0.511, P < 0.001; X(maternal): r = 0.535, P = 0.001) and with mother's height (all: r = 0.510, P < 0.001; X(maternal): r = 0.574, P < 0.001) but only weakly with father's height (all: r = 0.334, P = 0.015; X(maternal): r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with X(maternal) had a greater mean height gain than those with X(paternal) (sd score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04-0.82, P = 0.030, and for 45,X was +0.64 and 0.06-1.21, P = 0.031); X-linked imprinting explained 36-53% of the GH response. After pure tone audiometry testing, X(maternal) subjects were also less likely (P = 0.040) to have sensorineural hearing loss than X(paternal) subjects.METHODS AND RESULTSMicrosatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an X(maternal), whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact X(paternal). No significant differences were noted between X(maternal) and X(paternal) subjects for parents' heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with X(maternal), baseline height sd score correlated with midparental height (all: r = 0.511, P < 0.001; X(maternal): r = 0.535, P = 0.001) and with mother's height (all: r = 0.510, P < 0.001; X(maternal): r = 0.574, P < 0.001) but only weakly with father's height (all: r = 0.334, P = 0.015; X(maternal): r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with X(maternal) had a greater mean height gain than those with X(paternal) (sd score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04-0.82, P = 0.030, and for 45,X was +0.64 and 0.06-1.21, P = 0.031); X-linked imprinting explained 36-53% of the GH response. After pure tone audiometry testing, X(maternal) subjects were also less likely (P = 0.040) to have sensorineural hearing loss than X(paternal) subjects.This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.CONCLUSIONThis study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.
CONTEXT:Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X and 45,X individuals. OBJECTIVE AND DESIGN:We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height. METHODS AND RESULTS:Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an X, whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact X. No significant differences were noted between X and X subjects for parents’ heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with X, baseline height SD score correlated with midparental height (allr = 0.511, P < 0.001; Xr = 0.535, P = 0.001) and with mother’s height (allr = 0.510, P < 0.001; Xr = 0.574, P < 0.001) but only weakly with father’s height (allr = 0.334, P = 0.015; Xr = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with X had a greater mean height gain than those with X (SD score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04-0.82, P = 0.030, and for 45,X was +0.64 and 0.06-1.21, P = 0.031); X-linked imprinting explained 36-53% of the GH response. After pure tone audiometry testing, X subjects were also less likely (P = 0.040) to have sensorineural hearing loss than X subjects. CONCLUSION:This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.
CONTEXT: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X super(maternal) and 45,X super(paternal) individuals. OBJECTIVE: and Design: We evaluated the parent-of-origin effect of the intact X chromosome on spontaneous growth, GH-stimulated height gain, and frequency of sensorineural hearing loss in 54 subjects with Turner syndrome recruited from a Canadian randomized, controlled trial of GH supplementation to adult height. METHODS: and Results: Microsatellite analyses revealed that 72% of nonmosaic 45,X subjects retained an X super(maternal), whereas 86% of nonmosaic 46,X,i(Xq) subjects carried an intact X super(paternal). No significant differences were noted between X super(maternal) and X super(paternal) subjects for parents' heights, birth weight and length, and height, age, or bone age at study entry. In all subjects, and in those with X super(maternal), baseline height SD score correlated with midparental height (all: r = 0.511, P < 0.001; X super(maternal): r = 0.535, P = 0.001) and with mother's height (all: r = 0.510, P < 0.001; X super(maternal): r = 0.574, P < 0.001) but only weakly with father's height (all: r = 0.334, P = 0.015; X super(maternal): r = 0.292, P = 0.094). Using a linear model including age and height at GH initiation, subjects with X super(maternal) had a greater mean height gain than those with X super(paternal) (SD score difference and 95% confidence interval for all karyotypes was +0.43 and 0.04-0.82, P = 0.030, and for 45,X was +0.64 and 0.06-1.21, P = 0.031); X-linked imprinting explained 36-53% of the GH response. After pure tone audiometry testing, X super(maternal) subjects were also less likely (P = 0.040) to have sensorineural hearing loss than X super(paternal) subjects. CONCLUSION: This study provides evidence of an X-linked imprinting effect on GH response and on sensorineural hearing loss in Turner syndrome and should fuel the search for candidate genes.
Author Quigley, Charmian A.
Deal, Cheri L.
Hamelin, Catherine E.
Anglin, Greg
AuthorAffiliation Division of Experimental Medicine (C.E.H., C.L.D.), McGill University, Montreal, Québec, Canada H3A 1A3; Endocrinology Service and Research Center (C.E.H., C.L.D.), Hôpital Ste-Justine, Montreal, Québec, Canada H3T 1C5; Statistics (G.A.), Lilly Research Laboratories, Toronto, Ontario, Canada M4G 2P1; Endocrinology (C.A.Q.), Lilly Research Laboratories, US Medical, Indianapolis, Indiana 46258; and Department of Pediatrics (C.L.D.), University of Montreal, Montreal, Québec, Canada H3C 3J7
AuthorAffiliation_xml – name: Division of Experimental Medicine (C.E.H., C.L.D.), McGill University, Montreal, Québec, Canada H3A 1A3; Endocrinology Service and Research Center (C.E.H., C.L.D.), Hôpital Ste-Justine, Montreal, Québec, Canada H3T 1C5; Statistics (G.A.), Lilly Research Laboratories, Toronto, Ontario, Canada M4G 2P1; Endocrinology (C.A.Q.), Lilly Research Laboratories, US Medical, Indianapolis, Indiana 46258; and Department of Pediatrics (C.L.D.), University of Montreal, Montreal, Québec, Canada H3C 3J7
Author_xml – sequence: 1
  givenname: Catherine E.
  surname: Hamelin
  fullname: Hamelin, Catherine E.
  organization: 1Division of Experimental Medicine (C.E.H., C.L.D.), McGill University, Montreal, Québec, Canada H3A 1A3
– sequence: 2
  givenname: Greg
  surname: Anglin
  fullname: Anglin, Greg
  organization: 3Statistics (G.A.), Lilly Research Laboratories, Toronto, Ontario, Canada M4G 2P1
– sequence: 3
  givenname: Charmian A.
  surname: Quigley
  fullname: Quigley, Charmian A.
  organization: 4Endocrinology (C.A.Q.), Lilly Research Laboratories, US Medical, Indianapolis, Indiana 46258
– sequence: 4
  givenname: Cheri L.
  surname: Deal
  fullname: Deal, Cheri L.
  email: Cheri.L.Deal@umontreal.ca
  organization: 1Division of Experimental Medicine (C.E.H., C.L.D.), McGill University, Montreal, Québec, Canada H3A 1A3
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18026520$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16757526$$D View this record in MEDLINE/PubMed
BookMark eNqFkt1rFDEUxYNU7Lb65rMERH1xaj4nM75JqbuFBcFW8C3cZu64s51J1mTGpf-92e5KoVAMJCHwOyc35-aEHPngkZDXnJ1xwdmntTsTjJUFUzV7Rma8VrowvDZHZMaY4EVtxM9jcpLSmjGulJYvyDEvjTZalDPyZ44-DJ2jl8Mmdn7s_C_aeXo9RY-RXt35JoYBP9OLtkU3Jho8_Y5pE3xCOgY6j2E7rugixCFXRcE390SXbmlo6RX6FLIrThF6ukCIO_tlSOkled5Cn_DVYT8lP75eXJ8viuW3-eX5l2XhlNYyrwor06Cqm9IgGAeSAefMCaEbBFDGNA7YjcRKQ81aQN4wrdFJ5Fo1IE_J-73vJobfE6bRDl1y2PfgMUzJlpURyqjyvyCvZZlvExl8-whchxxWfoSVvFRKMF5VmXpzoKabARubsx0g3tl_wWfg3QGA5KBvI3jXpQeuYqLUgmXu455zMccWsX1AmN31366d3fXf7vqfcfEId90IYxf8GKHrnxKpvWgb-hFjuu2nLUa7QujHlWV5qNJUxU7Aqnwq8pQyyz7sZWHaPFXV_a-UfwEbGc3T
CODEN JCEMAZ
CitedBy_id crossref_primary_10_5507_bp_2020_060
crossref_primary_10_1530_EJE_17_0430
crossref_primary_10_1016_j_brainresbull_2011_06_018
crossref_primary_10_1515_jpem_2020_0104
crossref_primary_10_1016_j_bjorl_2013_08_002
crossref_primary_10_1016_j_jpeds_2009_02_052
crossref_primary_10_1111_j_1752_4571_2008_00017_x
crossref_primary_10_1007_s10803_021_04896_y
crossref_primary_10_1002_ajmg_b_31116
crossref_primary_10_1111_j_1365_2265_2007_02807_x
crossref_primary_10_1016_j_ics_2006_06_008
crossref_primary_10_6065_apem_2014_19_3_127
crossref_primary_10_1590_S1516_18462011005000081
crossref_primary_10_1186_s12882_020_01827_4
crossref_primary_10_1097_MED_0b013e32802e6d87
crossref_primary_10_1002_ajmg_a_37498
crossref_primary_10_1016_j_ics_2006_06_021
crossref_primary_10_1016_j_yfrne_2007_12_001
crossref_primary_10_3109_00016357_2012_734399
crossref_primary_10_1093_ejo_cjq196
crossref_primary_10_1210_jc_2006_0158
crossref_primary_10_1210_jc_2006_2874
crossref_primary_10_1002_hbm_21481
crossref_primary_10_1210_jc_2011_3488
crossref_primary_10_1044_1059_0889_2013_11_0027
crossref_primary_10_1002_ijc_25037
crossref_primary_10_1530_EJE_12_0404
crossref_primary_10_1007_s13760_013_0264_9
crossref_primary_10_1002_ajmg_c_31673
crossref_primary_10_1111_j_1365_2265_2010_03782_x
crossref_primary_10_1007_s00439_007_0324_4
crossref_primary_10_1016_j_ecl_2012_08_007
crossref_primary_10_1111_j_1749_6632_2010_05567_x
crossref_primary_10_1016_j_ejmg_2021_104169
crossref_primary_10_1111_j_1365_2265_2011_03937_x
crossref_primary_10_1210_er_2009_0039
crossref_primary_10_1007_s10577_009_9052_z
crossref_primary_10_1111_apa_15128
crossref_primary_10_1186_1687_9856_2013_10
crossref_primary_10_1089_jwh_2012_3931
crossref_primary_10_1530_EJE_13_0900
ContentType Journal Article
Copyright Copyright © 2006 by The Endocrine Society 2006
Copyright © 2006 by The Endocrine Society
2006 INIST-CNRS
Copyright_xml – notice: Copyright © 2006 by The Endocrine Society 2006
– notice: Copyright © 2006 by The Endocrine Society
– notice: 2006 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
H94
K9.
7TK
8FD
FR3
P64
RC3
7X8
DOI 10.1210/jc.2006-0490
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
Genetics Abstracts
Engineering Research Database
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts
MEDLINE
MEDLINE - Academic

Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 3010
ExternalDocumentID 16757526
18026520
10_1210_jc_2006_0490
00004678-200608000-00033
10.1210/jc.2006-0490
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
0R~
18M
1TH
2WC
34G
354
39C
4.4
48X
53G
5GY
5RS
5YH
8F7
AABZA
AACZT
AAIMJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
ABBLC
ABDFA
ABDPE
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVV
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
AELWJ
AEMDU
AENEX
AENZO
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFZL
AFGWE
AFOFC
AFRAH
AFXAL
AGINJ
AGKRT
AGQXC
AGUTN
AHMBA
AHMMS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BSWAC
BTRTY
C45
CDBKE
CS3
DAKXR
DIK
E3Z
EBS
EJD
EMOBN
ENERS
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
HZ~
J5H
KBUDW
KOP
KQ8
KSI
KSN
L7B
M5~
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
REU
ROX
ROZ
TEORI
TJX
TLC
TR2
TWZ
VVN
W8F
WOQ
X7M
YBU
YFH
YHG
YOC
YSK
ZY1
~02
~H1
29K
3O-
7X7
88E
8FI
8FJ
AAJQQ
AAKAS
AAPGJ
AAQQT
AAUQX
AAWDT
AAYJJ
ABUWG
ABXZS
ACFRR
ACVCV
ACZBC
ADMTO
ADNBA
ADZCM
AEMQT
AEOTA
AFFQV
AFKRA
AFYAG
AGMDO
AGORE
AHGBF
AI.
AJBYB
AJDVS
ALXQX
APJGH
AQDSO
AQKUS
AVNTJ
BENPR
BPHCQ
BVXVI
CCPQU
D-I
EIHJH
FEDTE
FYUFA
HMCUK
HVGLF
H~9
IAO
IHR
INH
ITC
M1P
MBLQV
NU-
OBFPC
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
TMA
UKHRP
VH1
WHG
X52
ZGI
ZXP
AAYXX
CITATION
IQODW
PJZUB
PPXIY
3V.
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
7QP
7T5
7TM
H94
K9.
7TK
8FD
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c4553-c44e87de49d67ea7ca30a110c225deaa477dca0b3e85a90fae1d055ec3e154da3
ISSN 0021-972X
IngestDate Fri Jul 11 08:41:45 EDT 2025
Fri Jul 11 03:24:16 EDT 2025
Mon Jun 30 12:44:09 EDT 2025
Wed Feb 19 01:43:46 EST 2025
Mon Jul 21 09:15:42 EDT 2025
Tue Jul 01 04:01:16 EDT 2025
Thu Apr 24 22:56:37 EDT 2025
Fri May 16 04:03:13 EDT 2025
Fri Feb 07 10:35:38 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Chromosomal aberration
Dysgenesia
Internal ear disease
Genital system
Somatotropin hormone
Auditory disorder
Sexual differentiation disorder
Turner syndrome
Epidemiology
Female genital diseases
Genomic imprinting
Adenohypophyseal hormone
Malformation
Gonad
Risk factor
ENT disease
Perception hearing loss
Sensory hearing loss
Endocrinology
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4553-c44e87de49d67ea7ca30a110c225deaa477dca0b3e85a90fae1d055ec3e154da3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
PMID 16757526
PQID 3164420188
PQPubID 2046206
PageCount 9
ParticipantIDs proquest_miscellaneous_68724746
proquest_miscellaneous_19364772
proquest_journals_3164420188
pubmed_primary_16757526
pascalfrancis_primary_18026520
crossref_primary_10_1210_jc_2006_0490
crossref_citationtrail_10_1210_jc_2006_0490
wolterskluwer_health_00004678-200608000-00033
oup_primary_10_1210_jc_2006-0490
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-August
PublicationDateYYYYMMDD 2006-08-01
PublicationDate_xml – month: 08
  year: 2006
  text: 2006-August
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2006
Publisher Oxford University Press
Copyright by The Endocrine Society
Endocrine Society
Publisher_xml – name: Oxford University Press
– name: Copyright by The Endocrine Society
– name: Endocrine Society
SSID ssj0014453
Score 2.0776584
Snippet Context: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,Xmaternal and...
CONTEXT:Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X and 45,X...
Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X(maternal) and...
CONTEXT: Evidence exists for X-linked parent-of-origin effects in Turner syndrome, because phenotypic and cognitive profiles differ between 45,X...
SourceID proquest
pubmed
pascalfrancis
crossref
wolterskluwer
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3002
SubjectTerms Age
Biological and medical sciences
Birth weight
Body height
Body Height - genetics
Chromosomes, Human, X - genetics
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Genetic disorders
Genetic Linkage
Genetic Predisposition to Disease
Genomic imprinting
Genomic Imprinting - genetics
Genotype
Growth hormones
Hearing loss
Hearing Loss, Sensorineural - complications
Hearing Loss, Sensorineural - genetics
Human Growth Hormone - therapeutic use
Humans
Karyotypes
Karyotyping
Medical sciences
Microsatellite Repeats - genetics
Parents
Recombinant Proteins - therapeutic use
Turner Syndrome - complications
Turner Syndrome - genetics
Turner's syndrome
Vertebrates: endocrinology
Title Genomic Imprinting in Turner Syndrome: Effects on Response to Growth Hormone and on Risk of Sensorineural Hearing Loss
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-200608000-00033
https://www.ncbi.nlm.nih.gov/pubmed/16757526
https://www.proquest.com/docview/3164420188
https://www.proquest.com/docview/19364772
https://www.proquest.com/docview/68724746
Volume 91
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQoxrYQw_wFOUykmcOOFtgm7lMl62SXuLnMQZHVsyrSlI_ER-FefYzqVTKw1eoio-uTTns8_F50LIW5AhfpB4ictB2XB5ngcuyPnEDUsVxiDRyyjDHd3Db9HshH8-DU9Hoz-DqKVlk03y32vzSv6Hq3AO-IpZsv_A2e6mcAJ-A3_hCByG4614fKB0UjGW-L2em5YP88oxzeudI1uLAG3-aRu1of31GBSrO2YcgA3efHdmoLfWldlHQAobbX4EFi6G5yldmWMGU0JnRNU2ZOO8x9mg_ESXaamqooYVqeprPF2qBhB30dYsNG5zZRvGd5mIznTSuybO7Chm0vQu2vmZdbRjrMAlrlB73TUfle5gAENwN-fr5KZXI269Gm2WgecmQrdaBzllFueEh67wTDxvu3on3gCl8WApDhjzB2IdFjK2VmSAzYsiQ5ezhNfgpnvpamXuGxKzi2NECwquT89zbOcZpXj1HXLXB5NFm_efvnQ7Wpzbiqj2f9kkDMygGj57RT0yKZcPruQC-FaaRivrLCGg-VVjcMXih86tGGhIx4_IQ2va0D2D020yUtVjcu_QBm88IT8tXGkPVzqvqIErbeH6nlqw0rqiLVhpU1MDVmrBSgFRmgLASuuSroCVWrBSBOtTcrI_Pf4wc23bDzfnYRjAkatYFIonRSSUFLkMmAQtNQfRUygpuRBFLlkWqDiUCSul8goWhioPFNgDhQyeka0KXuQFxu2JhEm_wLYKnHlFFsYqkjHLSpHkhc_HxGm_dprbmvjYmuUiXcfZMXnXUV-ZWjAb6CgwbhOJa0h2V7jaE8fMj0IfCHZaNqd2Ei_SwAPrBTT2OB6TN90wyAPc5JOVqpeLFAwyzC33N1NEsfC54NGYPDfw6R8eCbDefBhxV_CUmpzsVDsUQLvFRThCU1MXpQiCl7f8MK_I_X6u75Ct5nqpXoNO32S7erL8BQMd80Y
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genomic+Imprinting+in+Turner+Syndrome%3A+Effects+on+Response+to+Growth+Hormone+and+on+Risk+of+Sensorineural+Hearing+Loss&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Hamelin%2C+Catherine+E.&rft.au=Anglin%2C+Greg&rft.au=Quigley%2C+Charmian+A.&rft.au=Deal%2C+Cheri+L.&rft.date=2006-08-01&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=91&rft.issue=8&rft.spage=3002&rft.epage=3010&rft_id=info:doi/10.1210%2Fjc.2006-0490&rft.externalDBID=n%2Fa&rft.externalDocID=10_1210_jc_2006_0490
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon